Covid-19 and Diabetes Mellitus: A Life-Threatening Reciprocal Association

被引:0
作者
Sharma, Preeti [1 ]
Choudhry, Afreen Arshad [1 ]
Kumar, Pradeep [1 ]
Mahapatra, Tapan [1 ]
机构
[1] Santosh Deemed Univ, Santosh Med Coll, Dept Biochem, Ghaziabad, India
关键词
COVID-19; SARS-Cov-2; Diabetes mellitus; Co morbidities; CVD; RESPIRATORY SYNDROME CORONAVIRUS; CLINICAL CHARACTERISTICS; RISK; INHIBITORS; PNEUMONIA; PLASMA; WUHAN; CARE;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
COVID-19 has taken the world by storm and is now posing as a massive burden on the healthcare services of the world. Another long-standing global epidemic is Diabetes mellitus and Diabetics who get infected with COVID-19 have been seen to have worse outcomes and a high non-survival rate. The global focus is to control the pandemic for which diabetes has proved to be a vulnerable group. The present review aimed to assemble the information about Diabetes mellitus and COVID-19 mainly focusing on the interrelation of pandemics of the past and Diabetes mellitus, possible pathophysiological mechanisms governing COVID-19 in diabetics, the effect of COVID-19 infection on underlying Diabetes mellitus, morbidity, and mortality in diabetic COVID-19 patients and finally the management of Diabetes mellitus in the current pandemic.it is concluded that this COVID-19 pandemic is still lurking and it is of great importance to highlight the fact that a high percentage of the population of the world is affected by various comorbidities like diabetes mellitus, hypertension, COPD, obesity, etc which makes a subset of the population more vulnerable. This vulnerable population is at increased risk for a poor outcome if affected by COVID-19. Hence, we as a society should prioritize this population at risk to avoid adding additional burden to the already overburdened health care system in the present COVID-19 scenario.
引用
收藏
页码:38 / 43
页数:6
相关论文
共 47 条
[31]   COVID-19 and non-communicable diseases [J].
Pal, Rimesh ;
Bhadada, Sanjay K. .
POSTGRADUATE MEDICAL JOURNAL, 2020, 96 (1137) :429-430
[32]   COVID-19 and diabetes mellitus: An unholy interaction of two pandemics [J].
Pal, Rimesh ;
Bhadada, Sanjay K. .
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (04) :513-517
[33]   Type 1 interferons as a potential treatment against COVID-19 [J].
Sallard, Erwan ;
Lescure, Francois-Xavier ;
Yazdanpanah, Yazdan ;
Mentre, France ;
Peiffer-Smadja, Nathan .
ANTIVIRAL RESEARCH, 2020, 178
[34]  
Siyal FJ, 2020, ARCH PHARM PRACT, V11, P91
[35]   Analysis of Association between Vitamin D Deficiency and Insulin Resistance [J].
Szymczak-Pajor, Izabela ;
Sliwinska, Agnieszka .
NUTRIENTS, 2019, 11 (04)
[36]  
Tikellis Chris, 2012, Int J Pept, V2012, P256294, DOI 10.1155/2012/256294
[37]   Inflammation inhibitors were remarkably up-regulated in plasma of severe acute respiratory syndrome patients at progressive phase [J].
Wan, Jia ;
Sun, Wei ;
Li, Xiaohai ;
Ying, Wantao ;
Dai, Jingquan ;
Kuai, Xuezhang ;
Wei, Handong ;
Gao, Xue ;
Zhu, Yunping ;
Jiang, Ying ;
Qian, Xiaohong ;
He, Fuchu .
PROTEOMICS, 2006, 6 (09) :2886-2894
[38]   Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China [J].
Wang, Dawei ;
Hu, Bo ;
Hu, Chang ;
Zhu, Fangfang ;
Liu, Xing ;
Zhang, Jing ;
Wang, Binbin ;
Xiang, Hui ;
Cheng, Zhenshun ;
Xiong, Yong ;
Zhao, Yan ;
Li, Yirong ;
Wang, Xinghuan ;
Peng, Zhiyong .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (11) :1061-1069
[39]  
Wenzhong L, CHEMRXIV, V2020, DOI [10.26434/chemrxiv.11938173.v8, DOI 10.26434/CHEMRXIV.11938173.V8, 10.26434/ chemrxiv. 11938173.v7, DOI 10.26434/CHEMRXIV.11938173.V7]
[40]   Depressive symptoms, serious psychological distress, diabetes distress and cardiovascular risk factor control in patients with type 2 diabetes [J].
Winchester, Rhonda J. ;
Williams, Joni S. ;
Wolfman, Tamara E. ;
Egede, Leonard E. .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2016, 30 (02) :312-317